2019-11-15T13:20:55-06:00 2018-12-31 410746749 CLIFTONLARSONALLEN LLP 901 N GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2018-01-01 521006053 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVA 2027838700 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 2027838700 2019-11-13 1 AMY CHAPMAN P00843460 5712279500 67.137.57.251 2019-11-13 09:39:26 ES P 117C9FDD72C608EEAC637569487DFDD6D3A36660 3F26782FE4A8D097B8E6D44DA42E2066FBD559CC 2018 2020-04-17 16:48:07Z ADVAMED SCOTT WHITAKER 701 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 200042654 41344473 0 X WWW.ADVAMED.ORG X 1974 DE REPRESENT MEDICAL DIAGNOSTICS & DEVICE MANUFACTURERS ON REGULATORY & LEGISLATIVE ISSUES. 52 52 105 59 5668 94302 0 0 35244760 41086208 896051 201580 61271 56685 36202082 41344473 284000 232500 0 0 20278330 22243762 0 0 0 15361807 18686555 35924137 41162817 277945 181656 16551052 18080233 9302372 10683854 7248680 7396379 ADVAMED ADVOCATES ON A GLOBAL BASIS FOR THE HIGHEST ETHICAL STANDARDS, TIMELY PATIENT ACCESS TO SAFE AND EFFECTIVE MEDICAL TECHNOLOGIES, AND ECONOMIC POLICIES THAT REWARD VALUE CREATION. 0 0 ADVAMED'S GOVERNMENT AFFAIRS FUNCTION REPRESENTS THE INDUSTRY BEFORE STATE AND FEDERAL POLICYMAKERS, IN GOVERNOR'S OFFICES, STATE LEGISLATURES, THE UNITED STATES CONGRESS, AND RELEVANT FEDERAL AGENCIES. ADVAMED'S ADVOCACY STAFF AND OUTSIDE CONSULTANTS PROVIDE INFORMATION ON POLITICAL AND POLICY DEVELOPMENTS, AND PURSUE THE INDUSTRY'S AGENDA FOR A LEGAL, REGULATORY AND ECONOMIC ENVIRONMENT THAT ADVANCES HEALTH CARE BY ASSURING PATIENT ACCESS TO THE BENEFITS OF MEDICAL TECHNOLOGY. TAKING MEMBER COMPANY FEEDBACK FROM WORKING GROUPS AND COMMITTEES, ADVAMED STAFF PROVIDE CRITICAL INPUT TO REGULATORY AGENCIES LIKE FDA AND CMS ON REGULATIONS AND RULES THAT IMPACT THE ABILITY FOR PATIENTS TO RECEIVE TIMELY ACCESS TO LIFE CHANGING DEVICES PRODUCED BY ADVAMED MEMBERS. OUR CONSULTANTS IN JAPAN, CHINA, AND OTHER OVERSEAS MARKETS REPRESENT ADVAMED IN RAPIDLY EXPANDING OVERSEAS MARKETS AND ATTEND MEETINGS WITH GOVERNMENT OFFICIALS AND INDUSTRY COMMITTEE MEETINGS. THESE CONSULTANTS PROVIDE REAL-TIME INFORMATION AND AN INDUSTRY VOICE IN OVERSEAS MARKETS. 0 0 1 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 81 0 105 1 1 1 1 JA CH 0 0 0 0 1 0 X 52 52 0 0 1 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 X JENNIFER BREAREY 2027838700 701 PENNSYLVANIA AVENUE NW SUITE WASHINGTON DC 200042654 NADIM YARED CHAIRPERSON 1.00 X X 0 0 0 WALTER ROSEBROUGH TREASURER 1.00 X X 0 0 0 PETER ARDUINI SECRETARY 1.00 X X 0 0 0 NACHO ABIA DIRECTOR 1.00 X 0 0 0 BRIAN BLASER DIRECTOR 1.00 X 0 0 0 SCOTT BROOKS DIRECTOR 1.00 X 0 0 0 DOUG BRYANT DIRECTOR 1.00 X 0 0 0 JAMES CLEMMER DIRECTOR 1.00 X 0 0 0 JOSEPH DEVIVO DIRECTOR 1.00 X 0 0 0 TIMOTHY DUGAN DIRECTOR 1.00 X 0 0 0 DENNIS DURMIS DIRECTOR 1.00 X 0 0 0 LISA EARNHARDT DIRECTOR 1.00 X 0 0 0 R ANDREW ECKERT DIRECTOR 1.00 X 0 0 0 DAVID ENDICOTT DIRECTOR 1.00 X 0 0 0 BRIK EYRE DIRECTOR 1.00 X 0 0 0 CAMILLE FARHAT DIRECTOR 1.00 X 0 0 0 MICHAEL FARRELL DIRECTOR 1.00 X 0 0 0 VINCENT FORLENZA DIRECTOR 1.00 X 0 0 0 TODD FRUCHTERMAN DIRECTOR 1.00 X 0 0 0 JON GIACOMIN DIRECTOR 1.00 X 0 0 0 JOHN GROETELAARS DIRECTOR 1.00 X 0 0 0 STEFFEN HOVARD DIRECTOR 1.00 X 0 0 0 THOMAS KAPFER DIRECTOR 1.00 X 0 0 0 LIAM KELLY DIRECTOR 1.00 X 0 0 0 JOHN LIDDICOAT DIRECTOR 1.00 X 0 0 0 KEVIN LOBO DIRECTOR 1.00 X 0 0 0 STEPHEN MACMILLAN DIRECTOR 1.00 X 0 0 0 V GEORGE MALIEKEL DIRECTOR 1.00 X 0 0 0 DAMIEN MCDONALD DIRECTOR 1.00 X 0 0 0 ASHLEY MCEVOY DIRECTOR 1.00 X 0 0 0 BRIAN MILLER DIRECTOR 1.00 X 0 0 0 MICHAEL MINOGUE DIRECTOR 1.00 X 0 0 0 JEFF MIRVISS DIRECTOR 1.00 X 0 0 0 MICHAEL MUSSALLEM DIRECTOR 1.00 X 0 0 0 NAMAL NAWANA DIRECTOR 1.00 X 0 0 0 CAROLL NEUBAUER DIRECTOR 1.00 X 0 0 0 DAVID PACITTI DIRECTOR 1.00 X 0 0 0 DAVID PEREZ DIRECTOR 1.00 X 0 0 0 JACK PHILLIPS DIRECTOR 1.00 X 0 0 0 VITOR ROCHA DIRECTOR 1.00 X 0 0 0 SCOTT SCHORER DIRECTOR 1.00 X 0 0 0 MARTHA SHADAN DIRECTOR 1.00 X 0 0 0 BRADY SHIRLEY DIRECTOR 1.00 X 0 0 0 BENSON SMITH DIRECTOR 1.00 X 0 0 0 DOW WILSON DIRECTOR 1.00 X 0 0 0 JOSEPH WOODY DIRECTOR 1.00 X 0 0 0 LESTER KNIGHT DIRECTOR 1.00 X 0 0 0 F MICHAEL BALL DIRECTOR 1.00 X 0 0 0 DONALD CASEY DIRECTOR 1.00 X 0 0 0 PATRICK DALY DIRECTOR 1.00 X 0 0 0 MICHAEL GENAU DIRECTOR 1.00 X 0 0 0 JOHN GREISCH DIRECTOR 1.00 X 0 0 0 CHRIS HOLMES DIRECTOR 1.00 X 0 0 0 JOHN KILCOYNE DIRECTOR 1.00 X 0 0 0 MICHAEL PHALEN DIRECTOR 1.00 X 0 0 0 GLENN WARNER DIRECTOR 1.00 X 0 0 0 DEBORAH DISANZO DIRECTOR 1.00 X 0 0 0 BRYAN C HANSON DIRECTOR 1.00 X 0 0 0 BRENT SHAFER DIRECTOR 1.00 X 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 40.00 X 344143 0 52176 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 40.00 X 1463695 0 52200 CHRISTOPHER L WHITE CHIEF OPERATING OFFICER 40.00 X 719232 0 52200 RALPH IVES EXEC VP, GLOBAL STRATEGY 40.00 X 520051 0 33220 ANDREW FISH CHIEF STRATEGY OFFICER 40.00 X 706976 0 48800 JUAN CARLOS SCOTT CHIEF ADVOCACY OFFICER 40.00 X 540107 0 48748 SUSAN VAN METER EXECUTIVE DIRECTOR, ADVAMED DX 40.00 X 341593 0 7007 RAY BRISCUSO EXECUTIVE VICE PRESIDENT, CONFERENCES & EVENTS 40.00 X 334759 0 15558 STEVEN BROTMAN SVP, PMT & HEALTH CARE DEL 40.00 X 388913 0 48978 GREG CRIST EVP, PUBLIC AFFAIRS 40.00 X 438461 0 52200 ASHLEY WITTORF EXECUTIVE DIRECTOR, ADVAMED ACCEL 40.00 X 347286 0 52200 JANET TRUNZO EVP, TECH & REGULATORY AFF 40.00 X 563035 0 39178 DONALD MAY EVP, PMT & HEALTH CARE DEL 40.00 X 478167 0 48184 7186418 0 550649 55 0 1 0 ADFERO GROUP LLC 1666 K STREET NW SUITE 250 5TH F WASHINGTON DC 20006 PUBLIC RELATION CONSULTING 764033 WASHINGTON SPEAKERS BUREAU INC 1663 PRINCE STREET ALEXANDRIA VA 22314 PROVIDES SPEAKERS 638455 SPAG CONSULTING PRIVATE LIMITED 703 PALM COURT BUILDING SECTOR 14 GURGAON HARYANA IN CONSULTING SERVICES 366168 APCO BEIJING CONSULTING CO LTD SUITE 903 TOWER C OFFICE PARK NO CHAOYANG BEIJING CH CONSULTING SERVICES 351635 ARAMARKSFS 1101 ARCH STREET PHILADELPHIA PA 19107 CATERING SERVICES AT MTC 341888 41 MEMBERSHIP DUES 900099 33979655 33979655 MEETINGS & SEMINARS 611430 6494203 6494203 ASSESSMENTS 900099 612350 612350 41086208 201580 201580 51017 51017 JOB BOARD REVENUE 900099 5668 5668 5668 41344473 41086208 5668 252597 X 232500 5280562 14016923 1102467 975701 868109 802500 66418 3020165 4897633 12399 1167421 114374 1987506 1185442 4231398 499489 102985 DUES AND SUBSCRIPTIONS 412018 TRAINING 20646 166161 41162817 352 395 11734212 11212984 1700435 791161 529850 694845 6795127 6016819 980198 778308 1591825 1577253 2993590 14180 31697 16551052 18080233 4494042 5257446 1530749 1713070 3277581 3713338 9302372 10683854 X 7248680 7396379 7248680 7396379 16551052 18080233 X 181656 -33957 X 0 1 X 1 0 5000 5000 10000 1 ADVAMED CALIFORNIA PAC 701 PENNSYLVANIA AVENUE NW WASHINGTON DC 20004 455309081 5000 NYS DEMOCRATIC ASSEMBLY CAMPAIGN COMMITTEE 107 WASHINGTON AVENUE SUITE 1 LL ALBANY NY 12210 133041656 5000 0 0 1 30589897 3020165 -88358 2931807 3997230 -1065423 PART I-A, LINE 1: ADVAMED PROVIDED $5,000 OF FUNDING TO ADVAMED'S CALIFORNIA PAC AND PROVIDED $5,000 TO NYS DEMOCRATIC ASSEMBLY CAMPAIGN COMMITTEE. 3178510 2742031 436479 1044515 878915 165600 2572102 2395873 176229 778308 DEFERRED RENT 667449 DEFERRED COMPENSATION 1577253 DEFERRED TENANT ALLOWANCE 439409 DEFERRED ASSESSMENTS 1029227 3713338 X 41578972 234499 234499 41344473 0 41344473 41404859 242042 242042 41162817 0 41162817 PART X, LINE 2: ADVAMED COMPLIES WITH THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. MANAGEMENT EVALUATED ADVAMED'S TAX POSITIONS AND CONCLUDED THAT IT HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. PART XI, LINE 2D - OTHER ADJUSTMENTS: ADVAMED PAC REVENUE 188,973. ADVAMED CA PAC REVENUE 23,000. ADVAMED PURCHASING GROUP 22,526. PART XII, LINE 2D - OTHER ADJUSTMENTS: ADVAMED PAC EXPENSES 157,559. ADVAMED CA PAC EXPENSES 28,000. ADVAMED PURCHASING GROUP 56,483. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 2 10 PROGRAM SERVICES CONSULTANT IN ASIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 1590544 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 140139 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 5 PROGRAM SERVICES CONSULTANT IN EUROPE MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 498773 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 167432 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 3 PROGRAM SERVICES MEETINGS TO PROMOTE THE HARMONIZATION OF INTERNATIONAL STANDARDS 273280 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES CONSULTANT IN NORTH AMERICA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 51281 NORTH AMERICA - MEXICO AND CANADA 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 2355 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 2 PROGRAM SERVICES CONSULTANT IN BRAZIL MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 303127 SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 59491 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 2 PROGRAM SERVICES CONSULTANTS IN INDIA MEET WITH GOVERNMENT AND INDUSTRY OFFICIALS 454200 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 34998 MIDDLE EAST AND NORTH AFRICA - UAE 0 0 PROGRAM SERVICES STAFF TRAVEL TO REGION FOR MEETINGS 7349 2 20 0 2 2 22 3026931 556038 3582969 0 0 0 0 0 0 1 RESEARCH AMERICA 1101 KING STREET SUITE 520 ALEXANDRIA VA 22314 521609875 501(C)(3) 35000 PROGRAM SUPPORT ALLIANCE FOR AGING RESEARCH 750 17TH STREET NW SUITE 1100 WASHINGTON DC 20006 541379174 501(C)(3) 30000 PROGRAM SUPPORT UNITED SPINAL ASSOCIATION 75-20 ASTORIA BOULEVARD SUITE 120 JACKSON HEIGHTS NY 11370 135612621 501(C)(3) 30000 PROGRAM SUPPORT JUVENILE DIABETES RESEARCH FOUNDATION (JDRF) 1400 K STREET NW SUITE 725 WASHINGTON DC 20005 510150028 501(C)(3) 20000 PROGRAM SUPPORT SOCIETY FOR WOMEN'S HEALTH RESEARCH 1025 CONNECTICUT AVENUE NW SUITE 601 WASHINGTON DC 20036 521694732 501(C)(3) 15000 PROGRAM SUPPORT NATIONAL HEALTH COUNCIL 1730 M STREET NW SUITE 500 WASHINGTON DC 20036 131624107 501(C)(3) 12000 PROGRAM SUPPORT AIDS INSTITUTE INC 17 DAVIS BOULEVARD SUITE 403 TAMPA FL 33606 650380952 501(C)(3) 10000 PROGRAM SUPPORT LUNGEVITY FOUNDATION 228 SOUTH WABASH AVENUE SUITE 700 CHICAGO IL 60604 364433410 501(C)(3) 10000 PROGRAM SUPPORT PREVENT CANCER FOUNDATION 1600 DUKE STREET SUITE 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 10000 PROGRAM SUPPORT SPINA BIFIDA-ASSOCIATION OF AMERICA 4590 MACARTHUR BOULEVARD NW SUITE 250 WASHINGTON DC 20007 581342181 501(C)(3) 10000 PROGRAM SUPPORT HEALTHY WOMEN PO BOX 430 RED BANK NJ 07701 521624846 501(C)(3) 10000 PROGRAM SUPPORT AMERICAN CANCER SOCIETY CANCER ACTION NETWORK 555 11TH STREET SUITE 300 WASHINGTON DC 20004 522340031 501(C)(3) 10000 PROGRAM SUPPORT EVERYLIFE FOUNDATION 1012 14TH TSREET NW SUITE 500 WASHINGTON DC 20005 264614274 501(C)(3) 5500 PROGRAM SUPPORT BRYCE HARLOW FOUNDATION PO BOX 7762 MCLEAN VA 22106 521266620 501(C)(3) 5000 PROGRAM SUPPORT OVARIAN CANCER RESEARCH FUND ALLIANCE 14 PENN PLAZA SUITE 1710 NEW YORK NY 10122 133806788 501(C)(3) 5000 PROGRAM SUPPORT FRIENDS OF CANCER RESEARCH 1800 M STREET NW SUITE 1050 SOUTH WASHINGTON DC 20036 521983273 501(C)(3) 5000 PROGRAM SUPPORT NATIONAL DOWN SYNDROME SOCIETY 8 E 41ST STREET 8TH FLOOR NEW YORK NY 10017 132992567 501(C)(3) 5000 PROGRAM SUPPORT LUPUS AND ALLIED DISEASES ASSOCIATION 5279 TIDEN HILL ROAD VERONA NY 13478 161083229 501(C)(3) 5000 PROGRAM SUPPORT 18 1 PART I LINE 2: ADVAMED BUDGETS ANNUALLY FOR CHARITABLE DONATIONS AND OTHER CHARITABLE GIVING THAT IS CLOSELY ALIGNED WITH ITS STRATEGIC PLAN AND MISSION. IN ADDITION, ADVAMED MAY IDENTIFY CAUSES THROUGHOUT THE YEAR THAT MAY REQUIRE REPURPOSING OF FUNDS FROM ANOTHER EXPENSE CATEGORY TO SUPPORT CERTAIN MEDICAL DEVICE ISSUES OR MEMBERSHIP INITIATIVES, ALL SUCH SPENDING IS PROCESSED THROUGH ADVAMED'S PURCHASE ORDER SYSTEM, WHICH REQUIRES SEVERAL LEVELS OF EXECUTIVE APPROVAL BEFORE ANY FUNDING IS MADE. X X 1 1 X X X X X 0 0 0 JENNIFER BREAREY CHIEF FINANCIAL OFFICER 304212 0 39391 0 540 0 31898 0 20278 0 396319 0 0 0 SCOTT WHITAKER CHIEF EXECUTIVE OFFICER 983765 0 478688 0 1242 0 31898 0 20302 0 1515895 0 0 0 CHRISTOPHER L WHITE CHIEF OPERATING OFFICER 606173 0 110737 0 2322 0 31898 0 20302 0 771432 0 0 0 RALPH IVES EXEC VP, GLOBAL STRATEGY 420667 0 88260 0 11124 0 31898 0 1322 0 553271 0 0 0 ANDREW FISH CHIEF STRATEGY OFFICER 593152 0 112582 0 1242 0 28498 0 20302 0 755776 0 0 0 JUAN CARLOS SCOTT CHIEF ADVOCACY OFFICER 446645 0 92821 0 641 0 31898 0 16850 0 588855 0 0 0 SUSAN VAN METER EXECUTIVE DIRECTOR, ADVAMED DX 340850 0 0 0 743 0 5500 0 1507 0 348600 0 0 0 RAY BRISCUSO EXECUTIVE VICE PRESIDENT, CONFERENCE 332824 0 0 0 1935 0 5333 0 10225 0 350317 0 0 0 STEVEN BROTMAN SVP, PMT & HEALTH CARE DEL 338287 0 48304 0 2322 0 31898 0 17080 0 437891 0 0 0 GREG CRIST EVP, PUBLIC AFFAIRS 371951 0 65700 0 810 0 31898 0 20302 0 490661 0 0 0 ASHLEY WITTORF EXECUTIVE DIRECTOR, ADVAMED ACCEL 303133 0 43667 0 486 0 31898 0 20302 0 399486 0 0 0 JANET TRUNZO EVP, TECH & REGULATORY AFF 465139 0 86772 0 11124 0 31898 0 7280 0 602213 0 0 0 DONALD MAY EVP, PMT & HEALTH CARE DEL 418970 0 58387 0 810 0 31898 0 16286 0 526351 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS AUTHORIZED ONLY IN EXCEPTIONAL CIRCUMSTANCES, SUCH AS WHEN IT IS NECESSARY TO TAKE A SPECIFIC FLIGHT WHERE BUSINESS OR COACH CLASS IS NOT AVAILABLE, AND MUST FIRST HAVE PRIOR WRITTEN APPROVAL BY DEPARTMENT HEADS AND ADVAMED'S PRESIDENT. OTHER EXPENSES INCURRED BY THE TRAVELER FOR TRAVEL OUTSIDE THE DEFINITION OF A BUSINESS TRIP, INCLUDING EXPENSES FOR FAMILY MEMBERS TRAVELING WITH THE EMPLOYEE, ARE ALSO THE RESPONSIBILITY OF THE TRAVELER AND NOT ADVAMED. SUCH EXPENSES ARE KEPT SEPARATE FROM REIMBURSABLE BUSINESS EXPENDITURES. PERSONAL TRAVEL FOR FAMILY MEMBERS/FRIENDS MAY BE BOOKED THROUGH ADVAMED'S TRAVEL AGENCY BUT ARE IDENTIFIED SEPARATELY AND BILLED DIRECTLY TO THE EMPLOYEE. THE CEO OF ADVAMED MAY TRAVEL BUSINESS CLASS ON ALL INTERNATIONAL FLIGHTS AND FOR TRAVEL OVER THREE HOURS IN DURATION WHERE SUCH SEATING IS AVAILABLE. FIRST CLASS SEATING WILL BE REIMBURSED ON DOMESTIC FLIGHTS OVER THREE (3) HOURS IN DURATION IF BUSINESS CLASS SEATING IS NOT OFFERED ON THE FLIGHT. THE ASSOCIATION SHALL REIMBURSE TRAVEL EXPENSES FOR EXECUTIVE'S SPOUSE TO ASSOCIATION EVENTS WHEN ATTENDANCE IS REQUIRED FOR BUSINESS PURPOSES. TRAVEL IS NOT INCLUDED IN TAXABLE INCOME. FORM 990, PART VI, SECTION A, LINE 1 THERE SHALL BE AN EXECUTIVE COMMITTEE, WHICH SHALL CONSIST OF THE PRESIDENT, ELECTED OFFICERS OF THE ASSOCIATION, THE IMMEDIATE PAST CHAIRMAN, THE ADVAMED-DX CHAIRMAN, AND NOT FEWER THAN FIVE NOR MORE THAN TEN MEMBERS OF THE BOARD OF DIRECTORS AT LARGE, WHO SHALL BE ELECTED TO THAT POSITION, FOR A PERIOD OF ONE YEAR AND THEREAFTER UNTIL A SUCCESSOR SHALL HAVE BEEN DULY ELECTED AND QUALIFIED, BY A MAJORITY OF THE ENTIRE BOARD OF DIRECTORS ANNUALLY. THE EXECUTIVE COMMITTEE SHALL PERFORM SUCH DUTIES AS MAY BE DELEGATED TO IT BY THE BOARD OF DIRECTORS, AND MAY FURTHER ACT FOR AND ON BEHALF OF THE BOARD OF DIRECTORS BETWEEN MEETINGS OF THE BOARD OF DIRECTORS, PROVIDED THAT ALL SUCH ACTS SHALL BE FULLY REPORTED TO THE BOARD OF DIRECTORS AT OR BEFORE ITS NEXT MEETING FOR ITS REVIEW AND APPROPRIATE ACTION, IF REQUIRED OR DEEMED NECESSARY. FORM 990, PART VI, SECTION A, LINE 4 ADVAMED AMENDED ITS BYLAWS, EFFECTIVE JUNE 4, 2018, TO EXPAND THE BOARD FROM 50 TO 60 BOARD MEMBERS. FORM 990, PART VI, SECTION A, LINE 6 ANY FIRM OR CORPORATION WHICH, THROUGH ITSELF OR THROUGH ANY OF ITS SUBSIDIARIES OR DIVISIONS, IS SIGNIFICANTLY ENGAGED IN THE MANUFACTURE OF AND/OR THE RESEARCH WITH THE INTENT TO MANUFACTURE MEDICAL DEVICES, DIAGNOSTIC PRODUCTS AND/OR HEALTH CARE INFORMATION SYSTEMS WITHIN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, SHALL BE ELIGIBLE FOR ACTIVE MEMBERSHIP. FORM 990, PART VI, SECTION A, LINE 7A EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP, INCLUDING THE ELECTION OF ONE THIRD OF THE BOARD OF DIRECTORS ANNUALLY. THE BOARD NOMINATING AND GOVERNANCE COMMITTEE PRESENTS A PROPOSED SLATE OF DIRECTORS ANNUALLY TO THE MEMBERSHIP FOR VOTE. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. FORM 990, PART VI, SECTION A, LINE 7B EACH ACTIVE MEMBER IN GOOD STANDING SHALL BE ENTITLED TO ONE VOTE ON ANY QUESTION COMING BEFORE THE GENERAL MEMBERSHIP. EACH ACTIVE MEMBER SHALL, IN WRITING, DESIGNATE ITS OFFICIAL REPRESENTATIVE TO VOTE AND REPRESENT THAT MEMBER IN ALL OF THE AFFAIRS OF THE ASSOCIATION, INCLUDING THE HOLDING OF OFFICE. SUCH OFFICIAL REPRESENTATIVE SHALL BE THE CHIEF EXECUTIVE OFFICER OR CHIEF OPERATING OFFICER OF THE MEMBER OR SUCH OTHER SENIOR OPERATING OFFICER AS THE CHIEF EXECUTIVE OFFICER MAY DESIGNATE. FORM 990, PART VI, SECTION B, LINE 11B ADVAMED'S CHIEF FINANCIAL OFFICER AND CONTROLLER PERFORM AN INDEPTH REVIEW OF THE DRAFT 990. THE GENERAL COUNSEL REVIEWS THE FINAL DRAFT PRIOR TO SUBMITTING TO THE FINANCE, AUDIT AND COMPENSATION COMMITTEE (FAC). UPON THE FAC'S REVIEW THE 990 IS SUBMITTED TO THE FULL BOARD FOR THEIR REVIEW. PROVIDED NO CONCERNS ARE RAISED PRIOR TO THE END OF THE REVIEW PERIOD, THE 990 IS THEN FINALIZED AND SUBMITTED TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADVAMED HAS IN PLACE A CONFLICT OF INTEREST POLICY THAT IS MONITORED REGULARLY. EXCERPTS FROM THE POLICY RELATED TO THIS QUESTION ARE SHOWN BELOW: THE CONFLICT OF INTEREST POLICY OF ADVAMED: (1) DEFINES CONFLICTS OF INTEREST; (2) IDENTIFIES CLASSES OF INDIVIDUALS WITHIN THE ASSOCIATION COVERED BY THIS POLICY; (3) FACILITATES DISCLOSURE OF INFORMATION THAT MAY HELP IDENTIFY CONFLICTS OF INTEREST; AND (4) SPECIFIES PROCEDURES TO BE FOLLOWED IN MANAGING CONFLICTS OF INTEREST. 1. A CONFLICT OF INTEREST ARISES WHEN A PERSON IN A POSITION OF AUTHORITY OVER THE ASSOCIATION MAY BENEFIT FINANCIALLY FROM A DECISION HE OR SHE COULD MAKE IN THAT CAPACITY, INCLUDING INDIRECT BENEFITS SUCH AS TO FAMILY MEMBERS OR BUSINESSES WITH WHICH THE PERSON IS CLOSELY ASSOCIATED. ADVAMED'S POLICY IS FOCUSED UPON MATERIAL FINANCIAL INTEREST OF, OR BENEFIT TO, SUCH PERSONS. 2. PERSONS COVERED BY THIS POLICY ARE THE ASSOCIATION'S STAFF, OFFICERS, DIRECTORS, CHIEF EXECUTIVE OFFICER, AND CHIEF ADMINISTRATIVE OFFICER. 3. PERSONS COVERED BY THIS POLICY ANNUALLY DISCLOSE TO THE GENERAL COUNSEL ON A FORM PROVIDED BY THE ASSOCIATION THEIR INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, SUBSTANTIAL BUSINESS OR INVESTMENT HOLDINGS, AND OTHER TRANSACTIONS OR AFFILIATIONS WITH BUSINESSES AND OTHER ORGANIZATIONS OR THOSE OF FAMILY MEMBERS. 4. FOR EACH INTEREST DISCLOSED TO THE GENERAL COUNSEL, THE GENERAL COUNSEL WILL DETERMINE WHETHER TO: (A) TAKE NO ACTION; (B) ASSURE FULL DISCLOSURE TO THE BOARD OF DIRECTORS AND OTHER INDIVIDUALS COVERED BY THIS POLICY; (C) ASK THE PERSON TO RECUSE FROM PARTICIPATION IN RELATED DISCUSSIONS OR DECISIONS WITHIN THE ASSOCIATION; OR (D) ASK THE PERSON TO RESIGN FROM HIS OR HER POSITION IN THE ASSOCIATION OR, IF THE PERSON REFUSES TO RESIGN, BECOME SUBJECT TO POSSIBLE REMOVAL IN ACCORDANCE WITH THE ASSOCIATION'S REMOVAL PROCEDURES. THE ASSOCIATION'S CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER WILL MONITOR PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND DISCLOSE THEM TO THE CHAIRMAN OF THE BOARD OF DIRECTORS IN ORDER TO DEAL WITH POTENTIAL OR ACTUAL CONFLICTS, WHETHER DISCOVERED BEFORE OR AFTER THE TRANSACTION HAS OCCURRED. INTERESTS IN MEMBER COMPANIES: AT TIMES, ADVAMED STAFF AND/OR DIRECTORS MAY BE AWARE OF THE SIGNIFICANT AMOUNT OF INTEREST GENERATED IN CONNECTION WITH NEW PRODUCT DEVELOPMENT, SALES AND PROFITS, PRODUCT REGULATORY STATUS, AND ACQUISITIONS IN THE HEALTH CARE TECHNOLOGY INDUSTRY, THUS, ANYONE IN POSSESSION OF MATERIAL INFORMATION NOT GENERALLY AVAILABLE TO THE INVESTING PUBLIC MUST, IN ORDER TO COMPLY WITH THIS POLICY, EITHER DISCLOSE THAT KNOWLEDGE OR REFRAIN FROM TRADING IN THE STOCK. IN ADDITION, THE PURCHASE OF STOCK IN MEMBER COMPANIES CAN LEAD TO THE APPEARANCE THAT A MEMBER OF THE STAFF AND/OR BOARD OF DIRECTORS IS FAVORING THE INTERESTS OF THAT COMPANY BECAUSE OF SUCH FINANCIAL INTEREST. EVEN IF THERE IS NO ACTUAL CONFLICT OF INTEREST, THE APPEARANCE OF IMPROPRIETY MUST BE AVOIDED. NO EMPLOYEE OF THE ASSOCIATION OR MEMBER OF ITS BOARD OF DIRECTORS, EITHER IN HIS OR HER OWN NAME, OR IN THE NAME OF HIS OR HER SPOUSE OR CHILDREN, MAY PURCHASE STOCK IN ANY MEMBER COMPANY WITHOUT ADVISING THE ASSOCIATION PRESIDENT OF SUCH OWNERSHIP OR CONTEMPLATED OWNERSHIP. IN 2010, ADVAMED REQUIRED EMPLOYEES AND DIRECTORS TO SUBMIT AN ANNUAL FINANCIAL DISCLOSURE STATEMENT TO THE GENERAL COUNSEL REGARDING HOLDINGS IN MEMBER COMPANIES. AFTER REVIEW OF THE COMPLETED FORMS BY THE GENERAL COUNSEL, POTENTIAL CONFLICTS ARE REPORTED TO THE PRESIDENT, WHO REPORTS ANY SUCH DISCLOSURES TO THE CHAIRMAN OF THE BOARD OF DIRECTORS. INTEREST IN ENTITIES DOING BUSINESS WITH ADVAMED: IN THE COURSE OF ITS DAY-TO-DAY OPERATIONS, ADVAMED CONTRACTS WITH NUMEROUS FIRMS THAT PROVIDE GOODS AND SERVICES. IT IS IMPORTANT THAT THESE FIRMS ARE CHOSEN FOR BUSINESS PURPOSES AND NOT BECAUSE THEY ARE INAPPROPRIATELY FAVORED BY ADVAMED EMPLOYEES OR DIRECTORS WHO MAY HAVE A FINANCIAL INTEREST IN PARTICULAR TRANSACTIONS. ACCORDINGLY, ADVAMED EMPLOYEES AND DIRECTORS MUST DISCLOSE, ON AN ONGOING BASIS, ANY FINANCIAL INTEREST IN A COMPANY WITH WHICH ADVAMED CONTRACTS, OR IS CONSIDERING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS INCLUDES ALL OF THESE ELEMENTS: (1) REVIEW AND APPROVAL BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION; (2) USE OF DATA AS TO COMPARABLE COMPENSATION; AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING. 1. REVIEW AND APPROVAL: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED BY THE BOARD COMMITTEE ON FINANCE, AUDIT AND COMPENSATION OF THE ASSOCIATION, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. 2. USE OF DATA AS TO COMPARABLE COMPENSATION: THE COMPENSATION OF THE PERSON IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. 3. CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH IN SECTION 6104(D). FORM 990, PART IX, LINE 11G OTHER CONSULTING EXPENSE 4,897,633. FORM 990, PART XI, LINE 9: CHANGE IN EQUITY IN ADVAMED PURCHASING GROUP -33,957. MEDTECH CONFERENCE PARTNERS LLC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 364725626 TRADE SHOW DC 0 0 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION ADVANCED MEDICAL TECHNOLOGY ASSOCIATION POLITICAL ACTION COMMITTEE 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 522134566 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION CA PAC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 455309081 POLITICAL ACTION COMMITTEE DC 527 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 1 ADVAMED PURCHASING GROUP INC 701 PENNSYLVANIA AVENUE NW SUITE 80 WASHINGTON DC 20004 812764022 GROUP PURCHASING PROGRAM DC ADVANCED MEDICAL TECHNOLOGY ASSOCIATION C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1 PART III IN FEBURARY 2018, ADVAMED ENTERED INTO AN AGREEMENT WITH LIFE SCIENCES CONFERENCE GROUP, LLC (LCSG) TO PURCHASE THE REMAINING 50% OWNERSHIP OF MEDTECH CONFERENCE PARTNERS, LLC FOR THE AMOUNT OF $3,050,000. ADVAMED PAID LSCG $50,000 IN CONNECTION WITH THE EARLY TERMINATION OF THE MANAGEMENT AGREEMENT.